News & Articles

The tripartite mRNA technology has completed its phase 1b study for direct, intranodal injections in adjuvant melanoma patients

The certification indicates that the Aptima is the first and only diagnostic tool to incorporate both viral load and early infant diagnosis

New machine learning software can forecast the survival rates and response to treatments of patients with ovarian cancer

Calcium flow tracked in heart muscle fibres in real time

Optical topography to reduce patient burden in the treatment of attention-deficit hyperactivity disorder

Lonza and AllCells team up to offer an extensive range of hematopoietic primary cells to reach the global scientific community

Dr. Jim Aguanno explores the role of natriuretic peptides – NT-proBNP and BNP – in the diagnosis of heart failure

Extended screening service offers novel capabilities for immuno-oncology research in ex vivo T lymphocytes

New 10-color system with Kaluza C Software streamlines workflow and QC reporting for flow cytometric leukemia & lymphoma analysis

DiaSorin Molecular receives FDA clearance for Bordetella test

We asked you how science would change the world in the next 20 years – here's what you said

DNA from 15,000 patients analyzed to identify novel genetic associations

SelectScience is hosting two free CE-accredited events for healthcare professionals and laboratory scientists, but hurry - spots are filling up fast!

New molecular assay enables rapid antibiotic resistance result to support use of cost effective and convenient oral antibiotic for gonorrhea treatment

Multi-centre study published in New England Journal of Medicine suggests CAR-T therapy could improve outcome in B-cell lymphoma patients

Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition

Earn CE credits and learn how to overcome variability in flow injection, dried blood spot analysis, in our free webinar

New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission

Simplexa™ GBS Direct molecular assay enables in vitro detection of Group B Streptococcus

Cloud-based solution automatically records, tracks and monitors laboratory consumables for clinical laboratories